Several genes related to cell cycle arrest, apoptosis were increased and genes related to cell proliferation were significantly downregulated in Y79 cells when treated with EpCAM-specific siRNA.73 Hence, EpCAM can be considered a potential target molecule in the therapeutic interventions for RB management. The gene discussed is EPCAM; the disease is retinoblastoma.